Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Clobetasol propionate by AFYX Therapeutics for Vulvar Lichen Sclerosus: Likelihood of Approval
Clobetasol propionate is under clinical development by AFYX Therapeutics and currently in Phase II for Vulvar Lichen Sclerosus. According to...
Data Insights
Clobetasol propionate by AFYX Therapeutics for Aphthous Ulcers (Canker Sores): Likelihood of Approval
Clobetasol propionate is under clinical development by AFYX Therapeutics and currently in Phase I for Aphthous Ulcers (Canker Sores). According...